Synovus Financial’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-278,450
| Closed | -$1.86M | – | 937 |
|
|
2025
Q1 | $1.86M | Buy |
278,450
+114,557
| +70% | +$764K | 0.02% | 363 |
|
|
2024
Q4 | $2.06M | Buy |
163,893
+68,389
| +72% | +$860K | 0.03% | 350 |
|
|
2024
Q3 | $1.76M | Sell |
95,504
-72,586
| -43% | -$1.34M | 0.02% | 394 |
|
|
2024
Q2 | $3.62M | Buy |
168,090
+84,679
| +102% | +$1.82M | 0.05% | 245 |
|
|
2024
Q1 | $2.25M | Sell |
83,411
-1,559
| -2% | -$42K | 0.03% | 319 |
|
|
2023
Q4 | $2.55M | Buy |
84,970
+289
| +0.3% | +$8.66K | 0.04% | 290 |
|
|
2023
Q3 | $1.74M | Buy |
84,681
+3,699
| +5% | +$75.8K | 0.02% | 356 |
|
|
2023
Q2 | $1.61M | Sell |
80,982
-5,412
| -6% | -$108K | 0.02% | 373 |
|
|
2023
Q1 | $1.48M | Sell |
86,394
-42,520
| -33% | -$728K | 0.02% | 384 |
|
|
2022
Q4 | $2.52M | Buy |
128,914
+41,661
| +48% | +$815K | 0.03% | 302 |
|
|
2022
Q3 | $1.4M | Sell |
87,253
-408
| -0.5% | -$6.54K | 0.02% | 374 |
|
|
2022
Q2 | $1.21M | Buy |
87,661
+5,425
| +7% | +$74.8K | 0.01% | 406 |
|
|
2022
Q1 | $1.31M | Buy |
82,236
+18,663
| +29% | +$296K | 0.01% | 399 |
|
|
2021
Q4 | $1.38M | Buy |
63,573
+14,611
| +30% | +$317K | 0.01% | 390 |
|
|
2021
Q3 | $1.46M | Buy |
48,962
+6,824
| +16% | +$204K | 0.02% | 363 |
|
|
2021
Q2 | $1.87M | Buy |
42,138
+10,638
| +34% | +$471K | 0.02% | 316 |
|
|
2021
Q1 | $1.4M | Sell |
31,500
-16,572
| -34% | -$735K | 0.02% | 316 |
|
|
2020
Q4 | $2.64M | Sell |
48,072
-8,313
| -15% | -$456K | 0.03% | 236 |
|
|
2020
Q3 | $1.29M | Buy |
56,385
+4,841
| +9% | +$111K | 0.02% | 312 |
|
|
2020
Q2 | $1.08M | Sell |
51,544
-25,634
| -33% | -$537K | 0.02% | 318 |
|
|
2020
Q1 | $1.08M | Buy |
77,178
+44,678
| +137% | +$623K | 0.02% | 354 |
|
|
2019
Q4 | $740K | Buy |
+32,500
| New | +$740K | 0.01% | 387 |
|